Medtronic’s Evolut displays superior clinical outcomes
Medtronic has recently announced superior results from a three-year head-to-head study comparing the clinical outcomes of Medtronic’s Evolut and Edwards’…
Analyst Comment
Latest foreign investment in UK highlights underserved potential of primary care technology
ACC 2026: Post-TAVR treatments show potential in reducing cardiovascular risks
Epic secures a £222m federated EPR contract across Somerset and Dorset
Knight Therapeutics advances chronic GvHD expansion strategy
JPM26: Ypsomed commits to self-care delivery devices in new strategic plan
JPM26: Opus Genetics builds momentum in rare retinal gene therapy
JPM26: Butterfly Network aims to close the global medical imaging gap
